CorDynamics to Exhibit at 2009 Safety Pharmacology Society Meeting

Chicago, IL (August 2009) - CorDynamics heads to the 9th annual Safety Pharmacology Society Meeting, September 16-18, 2009 in Strasbourg, France. Scientific presentations will be held at the Palais de la Musique et des Congres. Dr. Michael R. Gralinski, CorDynamics CEO and former Safety Pharmacology Society President, will be among the experts in booth number 401 available to meet with colleagues, clients and new customers.

"CorDynamics has worked closely with the Safety Pharmacology Society for the past six years," says Dr. Gralinski. "We look forward to highlighting the proven solutions we provide for cardiovascular safety and discovery questions."

CorDynamics, Inc. is a comprehensive contract research organization and consulting group focused on examining the cardiovascular effects of emerging drug candidates. The company provides support with discovery and preclinical safety pharmacology studies along with lead optimization screening and consulting for more than 100 biopharmaceutical clients.

To learn more about the company, please visit our website at cordynamics.com. To schedule a private consultation with Dr. Gralinski please contact him at .

Contact:
Michael R. Gralinski, Ph.D., CorDynamics CEO